|
Neuronetics inc (NASDAQ: STIM) |
|
Neuronetics inc
STIM's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Neuronetics Inc growth rates, revenue grew
by 10.99 % in IV. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1612
Medical Equipment & Supplies industry recorded
deterioration of revenues by -0.3 %
Neuronetics Inc net loss increased from $-5 millions, to $-13 millions in IV. Quarter 2024,
• More on STIM's Growth
|
|
Neuronetics Inc realized a net loss in trailing twelve months.
Neuronetics Inc realized cash reduction of $ -1.27 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.82.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.14.
• More on STIM's Valuation
|
|
|
|
|
Neuronetics Inc realized net loss in trailing twelve months.
Neuronetics Inc realized cash outflow of $ -1.27per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.82.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.14.
Neuronetics Inc Price to Book Ratio is at 4.24 higher than Industry Avg. of -462.88, and higher than S&P 500 Avg. of 0.01
• More on STIM's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com